Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12.8M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.17M
-
Shares change
-
+83.2K
-
Total reported value, excl. options
-
$1.05M
-
Value change
-
+$53.6K
-
Number of buys
-
7
-
Number of sells
-
-3
-
Price
-
$0.90
Significant Holders of Biofrontera Inc. - Common Stock, par value $0.001 per share (BFRI) as of Q2 2024
14 filings reported holding BFRI - Biofrontera Inc. - Common Stock, par value $0.001 per share as of Q2 2024.
Biofrontera Inc. - Common Stock, par value $0.001 per share (BFRI) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.17M shares
of 12.8M outstanding shares and own 9.16% of the company stock.
Largest 10 shareholders include Rosalind Advisors, Inc. (504K shares), AIGH Capital Management LLC (501K shares), SCOTIA CAPITAL INC. (120K shares), GEODE CAPITAL MANAGEMENT, LLC (17.5K shares), Tower Research Capital LLC (TRC) (10.5K shares), UBS Group AG (10K shares), BlackRock Inc. (4.62K shares), OSAIC HOLDINGS, INC. (576 shares), WELLS FARGO & COMPANY/MN (91 shares), and BANK OF AMERICA CORP /DE/ (24 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.